Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine dose comparison for caudal block in children undergoing hypospadias repair
NL-OMON20616Active, not recruiting
- Sponsor
- Abbott Laboratories
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levobupivacaine in hypospadias (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Duration of analgesia. Started Mar 2005; status: active, not recruiting.
02
Drugs
levobupivacaine
03
Conditions
hypospadias
Beyond the preview
Go deeper on NL-OMON20616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20616.